2021
DOI: 10.1038/s41443-021-00498-5
|View full text |Cite
|
Sign up to set email alerts
|

Testosterone replacement therapy in the era of telemedicine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 50 publications
(53 reference statements)
0
1
0
Order By: Relevance
“…Fowler and Whitemore (1982) reported that exogenous testosterone given to metastasized prostate cancer patients resulted in increased advancement of malignant cells. 45 One longitudinal study found a signification between the relationship between men diagnosed with prostate cancer and endogenous testosterone supplementation. 46 However, a 3-year metaanalysis composed of 18 prospective studies with 3,500 men investigated the correlation between prostate cancer and TRT and found no association between serum androgen levels and the risk of prostate cancer.…”
Section: Prostate Dysfunction and Cancermentioning
confidence: 99%
“…Fowler and Whitemore (1982) reported that exogenous testosterone given to metastasized prostate cancer patients resulted in increased advancement of malignant cells. 45 One longitudinal study found a signification between the relationship between men diagnosed with prostate cancer and endogenous testosterone supplementation. 46 However, a 3-year metaanalysis composed of 18 prospective studies with 3,500 men investigated the correlation between prostate cancer and TRT and found no association between serum androgen levels and the risk of prostate cancer.…”
Section: Prostate Dysfunction and Cancermentioning
confidence: 99%